← Back to Search

Voiding Protocols After Minimally Invasive Hysterectomy

N/A
Recruiting
Led By Kristin Patzkowsky
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women 18+ undergoing minimally invasive benign, non-urogynecologic hysterectomy
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trialwill see if strict vs. liberal voiding affects post-op outcomes for patients discharged same-day after minimally invasive hysterectomy.

Who is the study for?
This trial is for women over 18 who speak English and are having a minimally invasive hysterectomy that isn't related to urology. They must be able to go home the same day of surgery. Women with past bladder surgeries, known urinary diseases, or those not leaving the hospital on the same day can't join.Check my eligibility
What is being tested?
The study is testing if it's necessary for patients to empty their bladders before going home after a non-urogynecologic hysterectomy. Participants will be randomly assigned either to a group that must void (pee) before discharge or one without this requirement.See study design
What are the potential side effects?
While there aren't direct side effects from voiding trials themselves, potential risks include increased chances of urinary retention (difficulty peeing), UTI, needing to return to the hospital, and possibly longer stays in recovery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman over 18 having a minor surgery to remove my uterus for non-cancer reasons.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rates of UTI
Rates of re-presentation to the ER
Rates of urinary retention
Secondary outcome measures
Amount of time spent in PACU
Cost of stay in PACU

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: No strict need to void following surgery before dischargeExperimental Treatment1 Intervention
Participants randomized to this arm will have no strict need to void following surgery before they are discharged.
Group II: Strict need to void following surgery before dischargePlacebo Group1 Intervention
Participants randomized to this arm will have a strict need to void following surgery before they are discharged.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,820,553 Total Patients Enrolled
1 Trials studying Urinary Retention
154 Patients Enrolled for Urinary Retention
Kristin PatzkowskyPrincipal InvestigatorJohns Hopkins University
Krisitn PatzkowskyPrincipal InvestigatorJohns Hopkins University

Media Library

No Strict need to void following surgery Clinical Trial Eligibility Overview. Trial Name: NCT05108506 — N/A
Urinary Retention Research Study Groups: Strict need to void following surgery before discharge, No strict need to void following surgery before discharge
Urinary Retention Clinical Trial 2023: No Strict need to void following surgery Highlights & Side Effects. Trial Name: NCT05108506 — N/A
No Strict need to void following surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05108506 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the participant count of this clinical investigation?

"Indeed, the details outlined on clinicaltrials.gov affirm that this medical trial is seeking participants. This research was originally announced December 5th 2022 and has since been updated on December 12th 2022. The study requires 100 individuals spread across 1 centre to take part in it."

Answered by AI

Are there still opportunities for participation in this medical experiment?

"Affirmative. According to information on clinicaltrials.gov, the trial that was initially launched on December 5th 2022 is now recruiting participants. 100 patients must be enrolled across a single site in order for this study to move forward successfully."

Answered by AI
~43 spots leftby Apr 2025